Does SUTIMLIMAB-JOME Cause Off label use? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Off label use have been filed in association with SUTIMLIMAB-JOME. This represents 8.6% of all adverse event reports for SUTIMLIMAB-JOME.
18
Reports of Off label use with SUTIMLIMAB-JOME
8.6%
of all SUTIMLIMAB-JOME reports
1
Deaths
2
Hospitalizations
How Dangerous Is Off label use From SUTIMLIMAB-JOME?
Of the 18 reports, 1 (5.6%) resulted in death, 2 (11.1%) required hospitalization, and 1 (5.6%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUTIMLIMAB-JOME. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does SUTIMLIMAB-JOME Cause?
Arthralgia (15)
Haemoglobin decreased (15)
Condition aggravated (12)
Drug ineffective (10)
Fatigue (10)
Haemolysis (10)
Headache (9)
Inappropriate schedule of product administration (8)
Covid-19 (7)
Cyanosis (7)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which SUTIMLIMAB-JOME Alternatives Have Lower Off label use Risk?
SUTIMLIMAB-JOME vs SUVOREXANT
SUTIMLIMAB-JOME vs SUZETRIGINE
SUTIMLIMAB-JOME vs SYMBICORT
SUTIMLIMAB-JOME vs SYNAGIS
SUTIMLIMAB-JOME vs SYNTHROID